P

Inventor

HADLOCK KENNETH G

US12 patents
⚠️ This page may combine multiple inventors who share the name “HADLOCK KENNETH G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENELABS TECH INC

6 patents
US6110662AAug 29, 2000

HTLV-I/HTLV-II assay and method

GENELABS TECH INC37 citations90
US5643714AJul 1, 1997

Method and assay for HTLV

GENELABS TECH INC3 citations57
US5871933AFeb 16, 1999

HTLV-I and HTLV-II peptide antigens and methods

GENELABS TECH INC0 citations51
US5814441ASep 29, 1998

HTLV-I and HTLV-II peptide antigens and methods

GENELABS TECH INC0 citations51
US5763572AJun 9, 1998

HTLV-II peptide antigens

GENELABS TECH INC0 citations51
US5614366AMar 25, 1997

HTLV-I peptide antigens and kit

GENELABS TECH INC0 citations51

FOUNG STEVEN K H

1 patent
US8114586B2Feb 14, 2012

Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes

FOUNG STEVEN K H68 citations93

UNIV STANFORD

1 patent
US6692908B1Feb 17, 2004

Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor

UNIV STANFORD41 citations91

UNIV LELAND STANFORD JUNIOR

1 patent
US7091324B2Aug 15, 2006

Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes

UNIV LELAND STANFORD JUNIOR14 citations82

Pathlogica LLC

1 patent
US7879914B2Feb 1, 2011

Methods for treating viral infections using polyamine analogs

Pathlogica LLC12 citations79

HADLOCK KENNETH G

1 patent
US8445540B2May 21, 2013

Regulation of osteopontin

HADLOCK KENNETH G9 citations75

PATHOLOGICA LLC

1 patent
US9867794B2Jan 16, 2018

Regulation of osteopontin

PATHOLOGICA LLC3 citations68